| Trade name of the product: |
| Darolac Plus |
| Pharmaceutical active ingredients: |
| Bifidobacterium LongumFructooligosaccharidesLactobacillus AcidophilusLactobacillus RhamnosusSaccharomyces Boulardii |
| Available forms, composition and doses of Darolac Plus: |
| Powder; Oral; Bifidobacterium Longum; Fructooligosaccharides; Lactobacillus Acidophilus; Lactobacillus Rhamnosus; Saccharomyces Boulardii |
| Medical categories: |
| Human:AntidiarrhealsGastrointestinal drugsSupplements and adjuvant therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A07FA51 - Lactic Acid producing organisms, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Aristo Pharmaceuticals |